好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Ultrasound-enhanced Electrical Impedance Tomography as a New Tool to Assess Primary Muscle Disease
Neuromuscular and Clinical Neurophysiology (EMG)
P4 - Poster Session 4 (8:00 AM-9:00 AM)
11-002
To learn if ultrasound-enhanced electrical impedance tomography (US-EIT) can distinguish muscle of healthy individuals and myopathy patients. 

Disorders of muscle are common. Diagnostic modalities include electromyography and biopsy. While valuable, the approaches are qualitative and invasive – and not well-suited for surveillance. Accordingly, there remains a need for quantitative measures of muscle health for longitudinal use in research trials and clinical care.

As a painless bedside technology, EIT could help meet this need. In EIT, weak electrical currents are applied through electrodes positioned over the skin; resultant surface voltages are translated into cross-sectional images that show how impedance is distributed throughout a region of interest. These impedance maps can be numerically transformed to evaluate characteristics including conductivity, permittivity, and phase. In this ongoing study, we are evaluating a combined US-EIT system that simultaneously collects ultrasound images and impedance data.

Using a standard ultrasound transducer covered by a specialized casing with imbedded impedance electrodes, measurements were obtained from deltoid, medial gastrocnemius, and tibialis anterior in healthy individuals and myopathy patients. Computerized three-dimensional reconstruction techniques and finite element modeling were used to determine and compare the conductivity, permittivity, and phase values of the two groups. A receiver operating characteristic curve was used to calculate the area under the curve (AUC) for phase.
To date, 4 healthy individuals and 3 patients with myopathy (dermatomyositis, Miyoshi myopathy, and myotonic dystrophy) aged 21-79 (average 52) years have been enrolled. Significant differences between healthy and patient muscle were found for permittivity (p=0.02) and phase (p<1e-3), with phase values showing the greatest difference (AUC=0.97); optimal sensitivity and specificity were 1.0 and 0.94 respectively.
These early data show that US-EIT holds promise as a new, non-invasive way to quantify differences in healthy and diseased muscle that could potentially reveal new aspects of disease impact.
Authors/Disclosures
Irene C. Yator, MD (University of Kentucky)
PRESENTER
Ms. Yator has nothing to disclose.
Ethan Murphy No disclosure on file
Hilda V. Gutierrez, MD (Beth Israel Deaconess Medical Center) Ms. Gutierrez has nothing to disclose.
Soleil Samaan (Beth Israel Deaconess Medical Center) No disclosure on file
Sarah Verga (Beth Israel Deaconess Medical Center) Miss Verga has nothing to disclose.
Courtney E. McIlduff, MD (Beth Israel Deaconess Medical Center) The institution of Dr. McIlduff has received research support from NIH - R21NSNS118434. The institution of Dr. McIlduff has received research support from NIH - R01MH111875. The institution of Dr. McIlduff has received research support from Blavatnik Family Fund. Dr. McIlduff has received publishing royalties from a publication relating to health care.
Seward B. Rutkove, MD, FAAN Dr. Rutkove has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Myolex, Inc. Dr. Rutkove has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Academy of Neuorlogy . The institution of Dr. Rutkove has received research support from NIH. The institution of Dr. Rutkove has received research support from NASA. The institution of Dr. Rutkove has received research support from Blavatnik Family Foundation. Dr. Rutkove has received intellectual property interests from a discovery or technology relating to health care. Dr. Rutkove has received intellectual property interests from a discovery or technology relating to health care. Dr. Rutkove has received publishing royalties from a publication relating to health care. Dr. Rutkove has received publishing royalties from a publication relating to health care. Dr. Rutkove has received personal compensation in the range of $500-$4,999 for serving as a Grant Reviewer with NIH.
Ryan Halter No disclosure on file